May 29, 2015November 5, 2015

Aeolus to Present Lung-ARS & IPF Therapy AEOL 10150 at Upcoming Conference

Aeolus Pharmaceuticals, Inc. has been invited to present data on the progress of the company’s contract with the Biomedical Advanced Research and Development Authority (BARDA) at the upcoming LD Micro Invitational Conference. ... Read more

May 6, 2015November 9, 2015

Aeolus Announces Positive Data on AEOL 10150 in Lung Injury Survival Rates

COPD, News

Aeolus Pharmaceuticals, Inc., a biotechnology firm funded mainly by the U.S. government, is developing a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. ... Read more